006280.KS Green Cross Corp. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
00:56
May 27
May 27
Green Cross exposed to Curevo
Green Cross holds a 50% stake in Curevo, which was acquired by Eli Lilly for up to $1.5 billion. This acquisition validates the value of Green Cross's vaccine pipeline and provides a significant cash inflow. The deal supports a positive revaluation of Green Cross's stake and its broader vaccine business.
MED
About 006280.KS Analyst Coverage
Buzzberg tracks 006280.KS (Green Cross Corp.) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked.